COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,387 Articles (22,816 medRxiv, 8,571 bioRxiv)

Most recent first Previous |  Page 166: Articles 1651-1660  | Next

Impact of an Oxidative RNA Lesion on in vitro Replication Catalyzed by SARS-CoV-2 RNA-dependent RNA Polymerase
Akagawa, M., Sugasawa, K., Ura, K., Sassa, A.
10.1101/2024.10.13.618053 — Posted: 2024-10-14
Green synthesized silver nanoparticles from Moringa: Potential for preventative treatment of SARS-CoV-2 contaminated water
Shittu, M. O., Bello, A. J., Ebunoluwa, O. B., Ayorinde, R. O., Onyepeju, N., Shaibu, J. O., Adewole, A. R., Adewole, A. O., Adedeji, O., Akinnusi, O. O., Oladapo, O. B., Popoola, T. S., Arotiba, O. M., Minari, J. B., Adams, L. A., Okpuzor, J.
10.1101/2024.10.12.617998 — Posted: 2024-10-14
Comparative assessment of machine learning algorithms to predict severity of disease in COVID-19 patients based on eight cofactors
Patel, T. S., Patel, D. P., El-Sayed, H., Sanyal, M., Shrivastav, P. S.
10.1101/2024.10.11.617884 — Posted: 2024-10-14
Synthesis and Evaluation of Carmofur Analogs as Antiproliferative Agents, Inhibitors to the Main Protease (Mpro) of SARS-CoV-2, and Membrane Rupture-Inducing Agents
Gu, T., Lu, A., Wang, X., Brahan, N., Xu, L., Zhang, L., Su, K., Seow, K., Vu, J., Luk, C., Lee, Y., Raman, A., Pazzi, J., Njoo, E.
10.1101/2024.10.11.617727 — Posted: 2024-10-14
Identification and Targeting of Regulators of SARS-CoV-2-Host Interactions in the Airway Epithelium.
Dirvin, B. G., Noh, H., Tomassoni, L., Cao, D., Zhou, Y., Ke, X., Qian, J., Schotsaert, M., Garcia-Sastre, A., Karan, C., Califano, A., Cardoso, W. V.
10.1101/2024.10.11.617898 — Posted: 2024-10-14
Integrative multi-ethnic Mendelian randomisation identifies tissue-specific causal genes for Coronary Artery Disease and interactions with post-acute Covid.
Jaros, R., O'Sullivan, J. M.
10.1101/2024.10.11.24315315 — Posted: 2024-10-13
Pre-pandemic national immunisation programme strength and health workforce capacity improved routine immunisation resilience during the COVID-19 pandemic
Evans, B., Kaiser, L., Keiser, O., Jombart, T.
10.1101/2024.10.09.24315115 — Posted: 2024-10-11
Performance of and preference for saliva sampling for detection of SARS-COV-2 in the Bahamas
Martin, I., McMillan, P.
10.1101/2024.10.10.24314969 — Posted: 2024-10-11
Association of COVID-19 risk factors with systemic fungal infections in hospitalized patients
Wilbourn, A. C., Tsodikov, O. V., Garneau-Tsodikova, S.
10.1101/2024.10.10.24315254 — Posted: 2024-10-11
Estimating the generation time for SARS-CoV-2 transmission using household data in the United States, December 2021 - May 2023
Chan, L. Y. H., Morris, S. E., Stockwell, M. S., Bowman, N. M., Asturias, E., Rao, S., Lutrick, K., Ellingson, K. D., Nguyen, H. Q., Maldonado, Y., McLaren, S. H., Sano, E., Biddle, J. E., Smith-Jeffcoat, S. E., Biggerstaff, M., Rolfes, M. A., Talbot, H. K., Grijalva, C. G., Borchering, R. K., Mellis, A. M., RVTN-Sentinel Study Group
10.1101/2024.10.10.24315246 — Posted: 2024-10-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).